This programme provides funding for IV iron infusions for patients who meet the PHARMAC special authority criteria for prescribing subsidised ferric carboxymaltose (Ferinject) in the community.
The infusion is to be provided in the community by the patient’s general practitioner.
This service is part of the Advanced Primary Options programme.
Your Pinnacle Services Contract applies to this service. By claiming for this service, you have indicated that you have read and agreed to the business rules set out here.
This is NOT a clinical guideline.
All Pinnacle practices in Waikato region can claim for this service.
Patients domiciled in Te Whatu Ora Waikato area.
Patients who meet the Special authority criteria for subsidised ferric carboxymaltose (Ferinject):
Please refer to the PHARMAC special authority criteria for Ferinject (SA1840).
Contraindications to using Ferinject in patients:
NB: allergic reactions are more common in people with a history of inflammatory diseases such as asthma, eczema and rheumatoid arthritis. Close observation is recommended for all patients whether or not they have had an iron infusion in the past (PDF).
Please make your claim by selecting Iron Infusion from the list of eligible services for indici practices or via advanced form for Medtech practices
Iron infusion: $150 (GST incl)
Please be aware the claim is all inclusive of the GP/NP consultation, administration of the infusion, observation time and consumables.
Please include either the Pharmac SA number or documentation of the secondary care request ( including the requesting department) with your claim.
A second claim may be made if the patient requires a divided dose of iron but please add this to the original case number.
Practices are required to provide sufficiently detailed consultation notes to determine appropriate use of funding.
Please include either the Pharmac SA number or documentation of the secondary care request ( including the requesting department) with your claim.
No. A patient co-payment cannot be charged. This service funds the administration of the infusion and there is no cost for the infusion to the patient, provided entry criteria are achieved. The funding for the service includes the co-payment for the initial GP/NP consultation followed by the nurse administration of the infusion.
This service does not include the cost of the medication on special authority, this is the responsibility of the patient to purchase.
The service is funded by Te Whatu Ora.
Primary options team, Pinnacle Midlands Health Network
infoprimaryoptions@pinnacle.health.nz
027 687 7312
A range of guides to assist when using the iron infusion programme.
Quick guides to assist practices with identifying eligibility criteria;invoices that can be claimed; managing claims and providing assistance with understanding remittance reports
Pinnacle has developed a rural chest pain assessment method that allows low-risk patients in rural communities to be safely assessed and managed by their general practice, rather than travelling significant distances to hospital - often needlessly.
Read morePathlab has reported BNP levels using the Triage Method and using EDTA plasma as the preferred sample type. The current reference interval is 0-100 ng/L. From 23 December 2024, the current BNP method will be replaced by NT-proBNP. This method is more specific than BNP, as NT-proBNP has a longer half-life and is less influenced by factors like obesity or kidney function.
Read moreTreatment of patients with low risk undifferentiated chest pain where the diagnosis is unclear, but the patient would otherwise be sent acutely to hospital for ECG. This funding does not cover the cost of a routine ECG
View detailsA range of guides to assist when using the iron infusion programme.